HealthDay News — Severe psoriasis, nail pitting, and the use of retinoids were identified as possible risk factors for development of psoriatic arthritis (PsA) among patients with psoriasis, according ...
—A new study from Weill Cornell Medicine found that patients with isolated nail psoriasis had nail findings for almost 3 years before they were diagnosed with psoriatic arthritis. It may be possible ...
In research published in Arthritis & Rheumatology, investigators developed and validated a tool called PRESTO that identifies patients with psoriasis who face an elevated risk for developing psoriatic ...
In research published in Arthritis & Rheumatology, investigators developed and validated a tool called PRESTO that identifies patients with psoriasis who face an elevated risk for developing psoriatic ...
Botulinum toxin A (BoNT-A) exhibited promising results for nail psoriasis for up to 6 months with a single injection. Botulinum toxin A (BoNT-A) injection emerged as an effective therapy for patients ...
Bristol Myers Squibb’s (BMY) Sotyktu has been approved by the US FDA to treat adults with active psoriatic arthritis (PsA). The approval is based on positive results from two phase 3 trials (POETYK ...
Philip J. Mease, MD: It was 30% in a study in which I was lead author. The study involved 40 different dermatology clinics with dermatologists specializing in psoriasis in North America and Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results